friends of FSH Research

Tagline

Identifying new therapies and understanding the pathogenesis of FSHD

— October 19, 2011

An update by Barbara D Page on the work done for the first of a 2-year project titled "Using model organisms to identify new therapies and understand the pathogenesis of FSHD."

Platform development and candidate drug screening for FSHD: Update

— September 6, 2011

The Miller Lab has made exciting progress in the development of a platform for screening genes and compounds with activities that affect FSHD-specific pathogenic processes.

Platform development and candidate drug screening for FSHD

— September 6, 2011

A major goal of the Seattle FSHD research consortium has been to develop platforms for drug discovery.

Summary of paper in Molecular Therapy from Joel R. Chamberlain and Davide Gabellini

— August 9, 2011

Summary of paper in Molecular Therapy from Joel R. Chamberlain and Davide Gabellini

FSHD Muscle Nuclei Poised for DUX4 Expression

— October 29, 2010

An international research consortium shows that FSHD muscle nuclei are poised for expression of the toxic DUX4 protein.